Burning Rock Biotech Ltd. ADR (BNR): Price and Financial Metrics
GET POWR RATINGS... FREE!
BNR Stock Price Chart Interactive Chart >
BNR Price/Volume Stats
|Current price||$2.66||52-week high||$29.16|
|Prev. close||$2.91||52-week low||$1.74|
|Day high||$2.98||Avg. volume||510,494|
|50-day MA||$3.32||Dividend yield||N/A|
|200-day MA||$9.53||Market Cap||279.59M|
Burning Rock Biotech Ltd. ADR (BNR) Company Bio
Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The company operates through following segment: central laboratory business, in-hospital business and pharma research and development services. Its products and clinical applications including companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction, and tumor susceptibility tests. Burning Rock Biotech was founded by Yu Sheng Han in 2014 and is headquartered in Guangzhou, China.
Most Popular Stories View All
BNR Latest News Stream
|Loading, please wait...|
BNR Latest Social Stream
View Full BNR Social Stream
Latest BNR News From Around the Web
Below are the latest news stories about Burning Rock Biotech Ltd that investors may wish to consider to help them evaluate BNR as an investment opportunity.
Investment company Yacktman Fund (Current Portfolio) buys Reliance Steel & Aluminum Co, Samsung C&T Corp, Associated British Foods PLC, Samsung Electronics Co, Hyundai Motor Co, sells Brenntag SE, Macy's Inc, The Walt Disney Co, Stanley Electric Co during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Yacktman Fund.
Investment company Yacktman Focused Fund (Current Portfolio) buys Reliance Steel & Aluminum Co, Samsung C&T Corp, Hyundai Motor Co, Yuasa Trading Co, Hyundai Motor Co, sells Brenntag SE, The Walt Disney Co, Macy's Inc, First Hawaiian Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Yacktman Focused Fund.
GUANGZHOU, China, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that, based on the latest operating trends, the Company expects its 2021 revenue to be at or slightly above RMB500 million. The Company is pleased with the recent progress achieved, despite elevated COVID impact that has been ongoing since the beginning of November, including the first diagnosed Omicron case in China and increased lock-downs in December.
GUANGZHOU, China, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that all shareholder resolutions proposed at the Company’s 2021 annual general meeting held today were duly passed. Specifically, the shareholders passed the following resolutions approving: the ratification of the appointment of Ernst
Brokerages forecast that Burning Rock Biotech Limited (NASDAQ:BNR) will announce earnings per share (EPS) of $0.12 for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Burning Rock Biotechs earnings. Burning Rock Biotech posted earnings of ($0.23) per share in the same quarter last year, which suggests a positive year-over-year growth 
BNR Price Returns